08:54 AM EDT, 08/18/2025 (MT Newswires) -- Health care stocks were flat to higher pre-bell Monday, with the iShares Biotechnology ETF (IBB) inactive and the Health Care Select Sector SPDR Fund (XLV) up 0.4%.

Novo Nordisk ( NVO ) shares were up more than 4% after the company said the US Food and Drug Administration approved a new indication for semaglutide to treat adults with metabolic-dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis, without cirrhosis.